Sensei Biotherapeutics CEO John Celebi's 2023 pay falls 35% to $1M
Sensei Biotherapeutics reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
Sensei Biotherapeutics reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, three executives at Sensei Biotherapeutics received on average a compensation package of $829K, a 22% decrease compared to previous year.
Average pay of disclosed executives at Sensei Biotherapeutics
John Celebi, Chief Executive Officer, received $1M in total, which decreased by 35% compared to 2022. 53% of Celebi's compensation, or $532K, was in salary. Celebi also received $286K in non-equity incentive plan, $100K in option awards, $30K in stock awards, as well as $64K in other compensation.
Edward van der Horst, Chief Scientific Officer, received a compensation package of $739K, which increased by 13% compared to previous year. 52% of the compensation package, or $383K, was in salary.
Erin Colgan, Chief Financial Officer, earned $734K in 2023, a 14% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2024.